Covid-19 roundup: European vaccines lobby pushing for liability protection; VBI vaccines to prep human trials – Endpoints News

At first glance, you might not be too impressed with the data from Dermavants Phase IIIs for their psoriasis contender tapinarof. The results pale in comparison to the biologics that have been transforming the field.

But Dermavant, a brainchild of biotech entrepreneur Vivek Ramaswamy, isnt about to go toe-to-toe with the heavyweights. Their cream treatment has a distinct commercial plan in place that leaves the most severe cases to the biologics, while positioning itself in the front of the market and quite possibly in combination with some of those blockbusters that have been stealing all the headlines.

Unlock this story instantly and join 89,000+ biopharma pros reading Endpoints daily and it's free.

SUBSCRIBE SIGN IN

Originally posted here:

Covid-19 roundup: European vaccines lobby pushing for liability protection; VBI vaccines to prep human trials - Endpoints News

Related Posts
Tags: